Search results
2 days ago · In mid-2023, the SWOG S1826 phase 3 trial in advanced Hodgkin lymphoma reported highly positive primary results earlier than expected, after the trial’s second planned interim analysis found the preset threshold for efficacy had already been reached.
2 days ago · Younger patients were able to participate in the clinical trial thanks to the leadership and advocacy of Kara Kelly, MD, the Waldemar J. Kaminski Endowed Chair of Pediatrics at Roswell Park Comprehensive Cancer Center, and Sharon Castellino, MD, MSc, Director of the Leukemia and Lymphoma Program at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, Professor of ...
1 day ago · If you need help accessing our website, call 855-698-9991
Sep 20, 2024 · Rated 5 out of 5 stars based on 233 patient reviews. 1. The dedicated team at Georgia Skin Cancer & Aesthetic Dermatology consists of 60 providers, administrators, and staff.
2 days ago · Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, USA Guillermo Umpierrez Department of Physical Medicine and Rehabilitation, Virginia Commonwealth University, Richmond ...
Sep 28, 2024 · KEYNOTE-671 was a global phase 3 trial done at 189 medical centres. Eligible participants (aged ≥18 years) with resectable stage II, IIIA, or IIIB (N2) NSCLC were randomly assigned (1:1) to four cycles of neoadjuvant pembrolizumab (200 mg administered intravenously every 3 weeks) plus cisplatin-based chemotherapy followed by surgery and 13 cycles of adjuvant pembrolizumab (200 mg ...
2 days ago · Terms. While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors.
